Jade Biosciences (JBIO) Change in Accured Expenses (2020 - 2026)

Jade Biosciences' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 396.3% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 306.98% YoY) and the FY2025 annual result came in at $3.9 million, up 2319.63% from the prior year.
• Change in Accured Expenses was $5.8 million for Q1 2026 at Jade Biosciences, up from -$3.5 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $10.1 million in Q4 2023 and bottomed at -$3.5 million in Q4 2025.
• A 5-year average of $1.3 million and a median of $590000.0 in 2024 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 5257.14% in 2022, while the deepest fall reached 6648.15% in 2022.
• Jade Biosciences' Change in Accured Expenses stood at -$1.8 million in 2022, then jumped by 672.0% to $10.1 million in 2023, then tumbled by 60.64% to $4.0 million in 2024, then slumped by 187.84% to -$3.5 million in 2025, then jumped by 265.1% to $5.8 million in 2026.
• Business Quant data shows JBIO's Change in Accured Expenses at $5.8 million in Q1 2026, -$3.5 million in Q4 2025, and $4.6 million in Q3 2025.